fat

Vivus Adds 12% in Early Trading on Qnexa Study Results

blood pressure, clinical study, diet, drug, fat, health, lipid, medical, medication, obesity, pharma, pill, placebo, qnexa, trade, vivus, vvus, weight loss

Vivus (VVUS) is up by double digits in early trading, after it says long-term data demonstrated patients treated with the investigational drug QNEXA for two years showed reductions in blood pressure and the use of antihypertensive

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

Bon-Ton Stores Trading Higher on 1.2x Ab...

Bon-Ton Stores's stock is up 3.0% to $9.35 on heavy trading volume. Approximately 321, ...

Trading Lower on Heavy Volume are Shares...

The price of Intersil shares has slipped to $13.00 (a 7.3% change) on heavy trading vol ...

Trading Lower on Heavy Volume are Shares...

Enterprise Products Partners shares are trading on heavy volume today, having fallen 1. ...

Trading Lower on Heavy Volume are Shares...

GlaxoSmithKline's stock is down 0.0% to $48.46 on heavy trading volume. About 4.0 mill ...

Sellers Reduce Exposure to Shares of Man...

Shares of Manulife Financial are trading today in above average volume, with the share ...

Trading Lower on Heavy Volume are Shares...

Tenaris shares are trading on heavy volume today, having fallen 3.4% to $43.29. About ...

Pacific Ethanol's Shares Changing Hands ...

The price of Pacific Ethanol shares has slipped to $17.50 (a 7.0% change) on heavy trad ...

Trading Lower on Heavy Volume are Shares...

Shares of Turkcell Iletisim Hizmet are trading down 0.2% to $16.39 today on above avera ...

Most Popular Video News